| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |